TopMedTalk ASA 2017 mission statement.

The start of our live coverage from Boston.

TopMedTalk @ ASA 2017

Should we still measure urine output? How useful is permissive oliguria?

This taken from a longer conversation on the subject of perioperative nephrology to be found here: http://www.topmedtalk.com/ebpom-2017-pod-one-live-from-london/

How do cell cycle arrest biomarkers offer hope?

Professor John Kellum gives a thumbnail sketch summary of the fluid debate.

Reactions to one of the big take away points of EBPOM 2017, intraoperative hypotension lower than 65 mmHg appears to show a close correlation to terrible, sometimes fatal, outcomes.

What is a 'micromort'? Even more of a worry, what does ten of them mean? How do we measure and communicate risk to patients? Everyday activities all carry inherent risks, how do we put surgery into a context 'everyday people' can more easily understand?

Recorded on day two of EBPOM 2017; Professor Monty Mythen presents with guests, Professor Sol Aronson, a tenured professor at Duke University and Executive Vice Chairman in the Department of Anesthesiology, and Dr Mike Irwin, Professor and Head, Department of Anaesthesiology, University of Hong Kong.

Sponsored by EBPOM and Edwards Life Sciences.

Join in the debate: [email protected]

Taken from a longer conversation to be found here: http://www.topmedtalk.com/ebpom-2017-pod-two-live-from-london/

Should we refuse surgery to those who won't change? What about pathological issues, such as smoking, should practitioners become more didactic in their approach? How do we effectively communicate risk, both to the patient and the institution you work for?

Recorded on day two of EBPOM 2017; Professor Monty Mythen presents with Dr Joff Lacey and guests, Professor Sol Aronson, a tenured professor at Duke University and Executive Vice Chairman in the Department of Anesthesiology, and Dr Mike Irwin, Professor and Head, Department of Anaesthesiology, University of Hong Kong.

Sponsored by EBPOM and Edwards Life Sciences.

Join in the debate: [email protected]

Taken from a longer conversation to be found here: http://www.topmedtalk.com/ebpom-2017-pod-two-live-from-london/

Fitness for surgery and an understanding of the realities of risk. How important is it for surgery to take place when balanced against the specific health of the patient? How do we encourage patients to alter pathological aspects of their lives in order to minimise the chances of a negative outcome?

Recorded on day two of EBPOM 2017; Professor Monty Mythen presents with Dr Joff Lacey and guests, Professor Sol Aronson, a tenured professor at Duke University and Executive Vice Chairman in the Department of Anesthesiology, and Dr Mike Irwin, Professor and Head, Department of Anaesthesiology, University of Hong Kong.

Sponsored by EBPOM and Edwards Life Sciences.

Join in the debate: [email protected]

Taken from a longer conversation to be found here: http://www.topmedtalk.com/ebpom-2017-pod-two-live-from-london/

Should we refuse Surgery to those who won't change?